Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta‐analysis of studie... von Dulucq, Stéphanie, Astrugue, Cyril, Etienne, Gabriel, Mahon, François‐Xavier, Benard, Antoine

Volltext

Deep Molecular Response in Chronic Myeloid Leukemia: The New Goal of Therapy? von MAHON, François-Xavier, ETIENNE, Gabriel

Volltext

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study von Rea, Delphine, Nicolini, Franck E., Tulliez, Michel, Guilhot, François, Guilhot, Joelle, Guerci-Bresler, Agnès, Gardembas, Martine, Coiteux, Valérie, Guillerm, Gaelle, Legros, Laurence, Etienne, Gabriel, Pignon, Jean-Michel, Villemagne, Bruno, Escoffre-Barbe, Martine, Ianotto, Jean-Christophe, Charbonnier, Aude, Johnson-Ansah, Hyacinthe, Noel, Marie-Pierre, Rousselot, Philippe, Mahon, François-Xavier

Volltext

How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapy von Rea, Delphine, Mahon, François‐Xavier

Volltext

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study von Rousselot, Philippe, Prost, Stéphane, Guilhot, Joelle, Roy, Lydia, Etienne, Gabriel, Legros, Laurence, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Huguet, Francoise, Cayssials, Emilie, Cayuela, Jean‐Michel, Relouzat, Francis, Delord, Marc, Bruzzoni‐Giovanelli, Heriberto, Morisset, Laure, Mahon, François‐Xavier, Guilhot, François, Leboulch, Philippe

Volltext

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia von Etienne, Gabriel, Guilhot, Joëlle, Rea, Delphine, Rigal-Huguet, Françoise, Nicolini, Franck, Charbonnier, Aude, Guerci-Bresler, Agnès, Legros, Laurence, Varet, Bruno, Gardembas, Martine, Dubruille, Viviane, Tulliez, Michel, Noel, Marie-Pierre, Ianotto, Jean-Christophe, Villemagne, Bruno, Carré, Martin, Guilhot, François, Rousselot, Philippe, Mahon, François-Xavier

Volltext

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imat... von Mahon, François-Xavier, Prof, Réa, Delphine, MD, Guilhot, Joëlle, PhD, Guilhot, François, Prof, Huguet, Françoise, MD, Nicolini, Franck, MD, Legros, Laurence, MD, Charbonnier, Aude, MD, Guerci, Agnès, MD, Varet, Bruno, Prof, Etienne, Gabriel, MD, Reiffers, Josy, Prof, Rousselot, Philippe, Prof

Volltext

How to interpret the EURO-SKI study and its treatment-free remission outcome. Reply to R.P. Gale and J. Chen von Pfirrmann, Markus, Saussele, Susanne, Mahon, François-Xavier, Richter, Johan

Volltext

Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients von Alcazer, Vincent, Morisset, Stéphane, Rea, Delphine, Legros, Laurence, Dulucq, Stéphanie, Hayette, Sandrine, Cayuela, Jean‐Michel, Huguet, Françoise, Mahon, François‐Xavier, Etienne, Gabriel, Nicolini, Franck E.

Volltext

"Discontinuation of TKI therapy and ‘Functional’ Cure for CML" von Mahon, François-Xavier, Pr

Volltext

Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib... von ROUSSELOT, Philippe, CHARBONNIER, Aude, ESCOFFRE-BARBE, Martine, GUERCI-BRESLER, Agnès, TULLIEZ, Michel, PROST, Stéphane, SPENTCHIAN, Marc, CAYUELA, Jean Michel, REIFFERS, Josy, CHOMEL, Jean Claude, TURHAN, Ali, GUILHOT, Joëlle, CONY-MAKHOUL, Pascale, GUILHOT, François, MAHON, François-Xavier, AGAPE, Philippe, NICOLINI, Franck E, VARET, Bruno, GARDEMBAS, Martine, ETIENNE, Gabriel, REA, Delphine, ROY, Lydia

Volltext

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group von Rea, Delphine, Ame, Shanti, Berger, Marc, Cayuela, Jean‐Michel, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Dubruille, Viviane, Dulucq, Stéphanie, Etienne, Gabriel, Legros, Laurence, Nicolini, Franck, Roche‐Lestienne, Catherine, Escoffre‐Barbe, Martine, Gardembas, Martine, Guerci‐Bresler, Agnès, Johnson‐Ansah, Hyacinthe, Rigal‐Huguet, Françoise, Rousselot, Philippe, Mahon, François‐Xavier

Volltext

Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study von Rea, Delphine, Henry, Guylaine, Khaznadar, Zena, Etienne, Gabriel, Guilhot, François, Nicolini, Franck, Guilhot, Joelle, Rousselot, Philippe, Huguet, Françoise, Legros, Laurence, Gardembas, Martine, Dubruille, Viviane, Guerci-Bresler, Agnès, Charbonnier, Aude, Maloisel, Frédéric, Ianotto, Jean-Christophe, Villemagne, Bruno, Mahon, François-Xavier, Moins-Teisserenc, Hélène, Dulphy, Nicolas, Toubert, Antoine

Volltext

Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of DASFREE von Shah, Neil P., García‐Gutiérrez, Valentín, Jiménez‐Velasco, Antonio, Larson, Sarah M., Saussele, Susanne, Rea, Delphine, Mahon, François‐Xavier, Levy, Moshe Yair, Gómez‐Casares, María Teresa, Mauro, Michael J., Sy, Oumar, Martin‐Regueira, Patricia, Lipton, Jeffrey H.

Volltext

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients von Nicolini, Franck Emmanuel, Dulucq, Stéphanie, Boureau, Lisa, Cony-Makhoul, Pascale, Charbonnier, Aude, Escoffre-Barbe, Martine, Rigal-Huguet, Françoise, Coiteux, Valérie, Varet, Bruno, Dubruille, Viviane, Lenain, Pascal, Rousselot, Philippe, Rea, Delphine, Guerci-Bresler, Agnès, Legros, Laurence, Liu, Jixing, Gardembas, Martine, Ianotto, Jean-Christophe, Turlure, Pascal, Johnson-Ansah, Hyacinthe, Martiniuc, Juliana, Jardel, Henry, Joly, Bertrand, Zunic, Patricia, Henni, Tawfiq, Villemagne, Bruno, Berger, Marc G, Cayssials, Emilie, Guilhot, François, Larosa, Fabrice, Guilhot, Joëlle, Etienne, Gabriel, Mahon, François-Xavier

Volltext

Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome von Berger, Marc G., Pereira, Bruno, Rousselot, Philippe, Cony‐Makhoul, Pascale, Gardembas, Martine, Legros, Laurence, Escoffre‐Barbe, Martine, Nicolini, Franck‐Emmanuel, Saugues, Sandrine, Lambert, Céline, Réa, Delphine, Guerci‐Bresler, Agnès, Giraudier, Stéphane, Guilhot, Joëlle, Saussele, Susanne, Mahon, François‐Xavier

Volltext

Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment‐free remission period after imatinib discontinuation: Results of the French... von Dulucq, Stéphanie, Rigal‐Huguet, Françoise, Nicolini, Franck E., Cony‐Makhoul, Pascale, Escoffre‐Barbe, Martine, Gardembas, Martine, Legros, Laurence, Rousselot, Philippe, Liu, Jixing, Rea, Delphine, De Mas, Véronique, Hayette, Sandrine, Raynaud, Sophie, Lacoste‐Roussillon, Caroline, Robbesyn, Fanny, Klein, Emilie, Morisset, Stéphane, Mahon, François‐Xavier, Etienne, Gabriel

Volltext

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 von Baccarani, Michele, Deininger, Michael W., Rosti, Gianantonio, Hochhaus, Andreas, Soverini, Simona, Apperley, Jane F., Cervantes, Francisco, Clark, Richard E., Cortes, Jorge E., Guilhot, François, Hjorth-Hansen, Henrik, Hughes, Timothy P., Kantarjian, Hagop M., Kim, Dong-Wook, Larson, Richard A., Lipton, Jeffrey H., Mahon, François-Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Pane, Fabrizio, Radich, Jerald P., Rousselot, Philippe, Saglio, Giuseppe, Saußele, Susanne, Schiffer, Charles, Silver, Richard, Simonsson, Bengt, Steegmann, Juan-Luis, Goldman, John M., Hehlmann, Rüdiger

Volltext

Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors von El Eit, Rabab, Itani, Abdul Rahman, Nassar, Farah, Rasbieh, Nagham, Jabbour, Mark, Santina, Ahmad, Zaatari, Ghazi, Mahon, François‐Xavier, Bazarbachi, Ali, Nasr, Rihab

Volltext

BCR::ABL1 digital PCR for treatment‐free remission prediction in chronic myeloid leukemia patients: An individual participant data meta‐analysis von Kockerols, Camille, Valk, Peter J. M., Dulucq, Stéphanie, Nicolini, Franck‐Emmanuel, Mahon, François‐Xavier, Atallah, Ehab, Mauro, Michael J., Radich, Jerald P., Bernardi, Simona, Russo, Domenico, Farina, Mirko, Mori, Silvia, Gambacorti‐Passerini, Carlo, Civettini, Ivan, Lu, Liu, Yeung, David, Branford, Susan, Colafigli, Gioia, Breccia, Massimo, Hogenbirk, Pauline, Rosmalen, Joost, Cornelissen, Jan J., Westerweel, Peter E.

Volltext